Search Results - Yannick Vandenplas

Informing Patients about Biosimilar Medicines: The Role of European Patient Associations by Yannick Vandenplas, Steven Simoens, Philippe Van Wilder, Arnold G. Vulto, Isabelle Huys

Connect to this object online.

The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysis by Yannick Vandenplas, Steven Simoens, Philippe Van Wilder, Arnold G. Vulto, Isabelle Huys

Connect to this object online.

Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians by Liese Barbier, Yannick Vandenplas, Steven Simoens, Paul Declerck, Arnold G. Vulto, Isabelle Huys

Connect to this object online.

Determinants of prescribing decisions for off-patent biological medicines in Belgium: a qualitative study by Yannick Vandenplas, Steven Simoens, Philippe Van Wilder, Arnold G. Vulto, Florian Turk, Isabelle Huys

Connect to this object online.

Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis by Yannick Vandenplas, Steven Simoens, Philippe Van Wilder, Arnold G. Vulto, Arnold G. Vulto, Isabelle Huys

Connect to this object online.

Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care by Yannick Vandenplas, Liese Barbier, Steven Simoens, Philippe Van Wilder, Arnold G. Vulto, Arnold G. Vulto, Isabelle Huys

Connect to this object online.

How to balance valuable innovation with affordable access to medicines in Belgium? by Steven Simoens, Khadidja Abdallah, Liese Barbier, Teresa Barcina Lacosta, Alessandra Blonda, Elif Car, Zilke Claessens, Thomas Desmet, Evelien De Sutter, Laurenz Govaerts, Rosanne Janssens, Teodora Lalova, Teodora Lalova, Evelien Moorkens, Robbe Saesen, Robbe Saesen, Elise Schoefs, Yannick Vandenplas, Eline Van Overbeeke, Ciska Verbaanderd, Ciska Verbaanderd, Isabelle Huys

Connect to this object online.